Sub-Total: $0.00
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Complimentary
Related products
-
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more -
Emerging Treatment Options for Pustular Psoriasis
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more -
Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Read more
